Cancer of the ovary, fallopian tube, and peritoneum

被引：86
|
作者：
Berek, Jonathan S. [1 ]
Crum, Christopher [2 ]
Friedlander, Michael [3 ]
机构：
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford Womens Canc Ctr, Stanford, CA 94305 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA
[3] Royal Hosp Women, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2012年 / 119卷
关键词：
GERM-CELL TUMORS; PHASE-III TRIAL; RECURRENT EPITHELIAL OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; SECONDARY CYTOREDUCTIVE SURGERY; PACLITAXEL-BASED CHEMOTHERAPY; TERM-FOLLOW-UP; STAGE-III; INTRAPERITONEAL CISPLATIN; INTRAEPITHELIAL CARCINOMA;
D O I：
10.1016/S0020-7292(12)60025-3
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：S118 / S129
页数：12
相关论文
共 50 条
  • [31] Can AI replace the Gynaecological Pathologist in Reporting Tumours of the Ovary, Fallopian Tube and Peritoneum? A Proposed Roadmap
    Allen, K.
    Breen, J.
    Zucker, K.
    Ravikumar, N.
    Hall, G.
    Orsi, N.
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S36 - S36
  • [32] Intrauterine lavage as a novel method of detecting somatic mutations present in high-grade serous cancer of the ovary, fallopian tube or peritoneum
    Smith, E.
    Paula, A. D. C.
    Lee, S. S.
    Selenica, P.
    Chi, D. S.
    Abu-Rustum, N. R.
    Weigelt, B.
    Roche, K. Long
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 91 - 91
  • [33] ABSENCE OF LEFT FALLOPIAN TUBE AND OVARY
    THOMPSON, P
    MEDICAL JOURNAL OF AUSTRALIA, 1970, 2 (05) : 251 - &
  • [34] PROSTAGLANDINS IN THE OVARY AND FALLOPIAN-TUBE
    GELETY, TJ
    CHAUDHURI, G
    BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1992, 6 (04): : 707 - 729
  • [35] Unilateral absence of the fallopian tube and ovary
    Mishell, DR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1938, 36 : 705 - 706
  • [36] Outcomes After Multiple Lines of Chemotherapy for Platinum-Resistant Epithelial Cancers of the Ovary, Peritoneum, and Fallopian Tube
    Griffiths, Richard Wyn
    Zee, Ying-Kiat
    Evans, Saran
    Mitchell, Claire L.
    Kumaran, Gireesh C.
    Welch, Richard S.
    Jayson, Gordon C.
    Clamp, Andrew R.
    Hasan, Jurjees
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (01) : 58 - 65
  • [37] Prognostic role of early versus late onset of bone metastasis in patients with carcinoma of the ovary, peritoneum and fallopian tube
    Sehouli, J.
    Olschewski, J.
    Schotters, V.
    Fotopoulou, C.
    Pietzner, K.
    ANNALS OF ONCOLOGY, 2013, 24 (12) : 3024 - 3028
  • [38] Preliminary results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
    Rose, P. G.
    Drake, R.
    Braly, P. S.
    Bell, M. C.
    Wenham, R. M.
    Hines, J. H.
    Alvarez-Secord, A.
    Soltes-Rak, E.
    Childs, B. H.
    Herzog, T. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] International Federation of Gynecology and Obstetrics Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Estimation of Survival in Patients With Node-Positive Epithelial Ovarian Cancer
    Pereira, Augusto
    Perez-Medina, Tirso
    Magrina, Javier F.
    Magtibay, Paul M.
    Rodriguez-Tapia, Ana
    Peregrin, Irene
    Mendizabal, Elsa
    Ortiz-Quintana, Luis
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (01) : 49 - 54
  • [40] Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
    Dahm-Kahler, Pernilla
    Borgfeldt, Christer
    Holmberg, Erik
    Staf, Christian
    Falconer, Henrik
    Bjurberg, Maria
    Kjolhede, Preben
    Rosenberg, Per
    Stalberg, Karin
    Hogberg, Thomas
    Avall-Lundqvist, Elisabeth
    GYNECOLOGIC ONCOLOGY, 2017, 144 (01) : 167 - 173
12345